• Latest Posts

Novartis Relies on Biotech to keep up its Solid Financial Performance

Antibody Treatment for Obesity and Type 2 Diabetes enters Phase II

In Depth 5 Jan 2017

What to Expect from European Biotech Finance in 2017

The 10 Biggest Clinical Success Stories of 2016 in European Biotech

What do the CAR-T Patient Deaths Mean for the Future of the Field?

European Pharma closes 2016 by launching new Biotech Startups

ADVERTISEMENT

UPDATE: No Clear Winner in the CRISPR Patent Battle

How is European Immuno-Oncology fighting Blood Cancer?

UPDATE: GSK is staging a comeback with a new Shingles Vaccine

Fighting for the next Asthma Blockbuster: Italy gets in the way of Novartis

Results from 45% of Clinical Trials are kept Secret

UPDATE: Future of CAR-T shaken by Novartis R&D Shuffle

ADVERTISEMENT